Principal Financial Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-123,285
Closed -$934K 2269
2019
Q3
$934K Buy
123,285
+18,705
+18% +$139K ﹤0.01% 1835
2019
Q2
$784K Buy
+104,580
New +$822K ﹤0.01% 1876
2016
Q2
Sell
-641,410
Closed -$5.8M 2202
2016
Q1
$5.8M Sell
641,410
-1,820,030
-74% -$16.3M 0.01% 1320
2015
Q4
$22.8M Buy
2,461,440
+1,229,565
+100% +$13.5M 0.03% 503
2015
Q3
$15.7M Buy
1,231,875
+445,220
+57% +$5.53M 0.02% 658
2015
Q2
$8.7M Buy
786,655
+96,505
+14% +$1.07M 0.01% 1086
2015
Q1
$7.88M Buy
690,150
+151,920
+28% +$1.61M 0.01% 1123
2014
Q4
$5.43M Sell
538,230
-97,080
-15% -$1.02M 0.01% 1336
2014
Q3
$6.68M Buy
635,310
+50,750
+9% +$477K 0.01% 1171
2014
Q2
$5.04M Sell
584,560
-2,585,130
-82% -$21.7M 0.01% 1383
2014
Q1
$27.8M Buy
3,169,690
+2,343,270
+284% +$20.4M 0.05% 384
2013
Q4
$6.78M Sell
826,420
-76,190
-8% -$603K 0.01% 1149
2013
Q3
$6.82M Buy
902,610
+604,260
+203% +$4.4M 0.01% 1058
2013
Q2
$2.26M Buy
+298,350
New +$2.18M 0.01% 1568

Other funds holding RDY

Principal Financial Group's RDY Position: Q4 2019 in Review

Principal Financial Group sold out of Dr. Reddy's Laboratories (RDY) in Q4 2019, closing a stake of 123,285 shares — an estimated $934K sold.

Principal Financial Group first reported a position in RDY in Q2 2013 and held it in 14 quarters. The position peaked at $27.8M in Q1 2014. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

  • Principal Financial Group reported no remaining Dr. Reddy's Laboratories position as of Q4 2019 after selling out during the quarter.
  • Principal Financial Group sold 123,285 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $934K.
  • Principal Financial Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 14 quarters.
  • Principal Financial Group's Dr. Reddy's Laboratories position peaked at $27.8M in Q1 2014.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Principal Financial Group's 13F filing for Q4 2019, filed 5 Feb 2020.